Low DNA Input
FFPE tissue ≥40ng.
Oncology Fusion-Gene Variant Assay
Oncology Fusion-Gene Variant Assay
The Oncology Fusion-Gene Variant Assay is a qualitative in vitro diagnostic assay that uses hybrid capture-based next-generation sequencing (NGS) technology to detect gene fusions in 150 tumor-related genes from FFPE tissue samples of patients with solid tumors, enabling comprehensive treatment decisions for cancer patients.
The assay is able to detect gene fusions or rearrangements across 150 key genes, covering those recommended by NCCN/ESMO guidelines, expert consensus, and clinical trials.
High Sensitivity (LoD)
As high as 3 copies/ng.
Broad Target Coverage
Full coding regions (150 genes) + UTR regions (57 genes).
Workflow Flexibility
Automation and manual workflows available per your needs.